
Since the study period ended, new results show a long-term cardioprotective benefit for empagliflozin and liraglutide.
Mary Caffrey is the Executive Editor for The American Journal of Managed Care® (AJMC®). She joined AJMC® in 2013 and is the primary staff editor for Evidence-Based Oncology, the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for AJMC®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for AJMC readers.
Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on LinkedIn.

Since the study period ended, new results show a long-term cardioprotective benefit for empagliflozin and liraglutide.

The American Hospital Association is among those asking for a rating system that reflects socioeconomic differences in hospital populations.

The health groups' letter comes after CSPI's February report, Carbonating the World, which spelled out global investment by Coca-Cola and PepsiCo.

The charges filed today are "only the beginning," according to Michigan's attorney general. Months of denial from state officials gave way when a pediatrician produced results showing elevated lead levels in children's blood.

Early reports to the state's largest newspaper resemble tales from the days of Medicaid transitions in other states. While managed care may be better for accountability measures over the long haul, in state after state, large-scale transitions prove difficult.

The results, published in Diabetes Care, move the hope of pancreatic cell islet transplants close to commercialization, which would bring the technique to more patients who cannot produce their own insulin.

From the focus on prevention to the possibilities of telehealth, the annual meeting presented by The American Journal of Managed Care and Joslin Diabetes Center showed where care is heading.

The authors say increased attention to gut and adipose hormones will reveal pathways to treat infertility.

The widespread switch from regular to electronic cigarettes among teens has alarmed public health officials, who say nicotine in any form can harm brain development.

The rise in employee cost-sharing for healthcare predates Obamacare but has taken off since the law passed in 2010. Higher deductibles have been accompanied by stagnant wages, ensuring that the higher payments are deeply felt.

The study, funded by Medtronic, follows an earlier study that compared pump users to those using daily injections to manage type 2 diabetes.

The effort to allow counselors to deny mental health services comes a week after Mississippi Governor Phil Bryant signed a law to let counselors escape similar liability and let physicians deny transgender patients access to gender reassignment care.

FDA classifies this as a Class I recall, which means using the device could result in adverse health effects or death.

Concern about overnight hypoglycemic events drives decision-making for patients with type 1 diabetes.

The expansion follows an early demonstration project that showed that what happens between visits is critical for patients with chronic conditions.

While payer coverage for obesity care has improved since the American Medical Association declared that obesity is a disease, there's still a long way to go. Physician training must improve to eliminate stigma that keeps patients from getting care they need, according to experts who appeared at Patient-Centered Diabetes Care.

CMS' plan to pay for the National Diabetes Prevention Program is an important step toward payer coverage of technology-based diabetes care. But reimbursement for telehealth to treat type 2 diabetes remains challenging.

Growth in retail health clinics reveals unmet medical needs for Americans who lack insurance, who cannot leave work, or who have disconnected with the health system. This growing sector of the health system is diagnosing and treating diabetes cases that would otherwise be missed.

Lonny Reisman, MD, CEO of HealthReveal, told attendees at Patient-Centered Diabetes Care that harnessing multiple disparate data sources can help physicians deliver better solutions at the point of care.

The lawsuit, brought in 2005, took a turn in 2014 when a federal judge ordered the state to reach an agreement with the plaintiffs after finding the Florida failed to provide adequate healthcare to poor children.

The World Health Day theme highlighted the need to prevent the disease in the developing world, and the fact that many groups play a part

The warnings on labels will come after FDA reviewed long-term safety data.

While this study focused on calculating the global burden of diabetes, it comes as advocacy groups are stepping up calls for soda taxes marketing limits to rein in the effect of unhealthy food and drink on poor countries.

STAMPEDE was one of the first studies to suggest that patients who did not meet the traditional criteria for bariatric surgery might be candidates for treatment of type 2 diabetes, not just obesity.

The nation's top food and drug regulator enjoyed a warm welcome from colleagues on the final day of the 65th Scientific Session of the American College of Cardiology.

While overall data did not suggest a benefit for the drugs, a look at the effects on patients whose cardiac arrests were witnessed shows the benefit of reaching patients quickly.

The data were submitted to the FDA following idarucizumab’s accelerated approval last year, which is granted to therapies that address an unmet medical need.

Results from the GAUSS-3 trial presented Sunday at the American College of Cardiology should be good news for Amgen, but an editorial in JAMA says the cost of evolocumab exceeds "willingness to pay" limits.

A small study of sudden out-of-hospital deaths raises questions about the quality of primary care, especially for women.

The 2013 guideline update from the American College of Cardiology and the American Heart Association drew criticism when it was presented. Data presented in today's poster session at the ACC Scientific Session revealed unexpected results.

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
